Cleared Traditional

K820177 - COAGULASE PLASMA

K820177 is the FDA 510(k) clearance for COAGULASE PLASMA by Quadroma, Inc.. It is a Class 1 Microbiology device (product code JTL) cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K820177 · Quadroma, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1982
Decision
14d
Days
Class 1
Risk

K820177 is an FDA 510(k) clearance for the COAGULASE PLASMA. Classified as Plasma, Coagulase, Human, Horse And Rabbit (product code JTL), Class I - General Controls.

Submitted by Quadroma, Inc. (Mchenry, US). The FDA issued a Cleared decision on February 5, 1982 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2160 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Quadroma, Inc. devices

Submission Details

510(k) Number K820177 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 1982
Decision Date February 05, 1982
Days to Decision 14 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 102d · This submission: 14d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JTL Plasma, Coagulase, Human, Horse And Rabbit
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2160
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JTL Plasma, Coagulase, Human, Horse And Rabbit

All 8
Devices cleared under the same product code (JTL) and FDA review panel - the closest regulatory comparables to K820177.
HEMASTAPH
K840553 · Remel Co. · Apr 1984
API STAPHASE III
K833988 · Analytical Products, Inc. · Dec 1983
COAGULASE PLASMA, HORSE & RABBIT EDTA
K833858 · Otisville Biotech, Inc. · Dec 1983
RABBIT COAGULASE PLASMA
K812602 · Dutchland Laboratories, Inc. · Sep 1981
STAPHASE*
K811982 · Analytical Products, Inc. · Jul 1981
COAGULASE PLASMA
K792235 · Remel Co. · Dec 1979